Carvykti
Johnson & Johnson Overcomes CAR-T Drug Carvykti’s Launch Challenges with Manufacturing Improvements
Anika Sharma
Johnson & Johnson (J&J) and Legend Biotech are determined to expand the reach of their CAR-T drug Carvykti for multiple ...
J&J confident in new products as Stelara faces biosimilar threat
Anika Sharma
In the third quarter of 2023, Johnson & Johnson (J&J) exceeded analyst expectations, solidifying its position as a pharma and ...
Carvykti CAR-T Therapy by J&J and Legend Biotech Persists Amid New Bispecific
Anika Sharma
Johnson & Johnson and Legend Biotech’s Carvykti maintains growth in the multiple myeloma market despite the emergence of a more ...
Johnson & Johnson (J&J) Moves Closer to FDA Approval for CAR-T Therapy
SG Tylor
The company has filed for approval to use Carvykti earlier in the treatment pathway, including for patients experiencing their first ...
